Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick H Nachman

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Nature Reviews. Nephrology|April 23, 2009
Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?Patrick H Nachman
Clinical Journal of the American Society of Nephrology : CJASN|May 15, 2025
Progress Toward a Better Predictor of Remission in Anti-Phospholipase A2 Receptor-Associated Membranous NephropathyPatrick H Nachman
Kidney International|September 24, 2018
Repeat kidney biopsy for lupus nephritis: an important step forwardPatrick H Nachman
Nature Reviews. Nephrology|December 14, 2020
Advances in ANCA-associated vasculitis and lupus nephritisIsabelle Ayoub, Patrick H Nachman
Bone Marrow Transplantation|August 19, 2023
Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disordersVeronika Bachanova, Patrick H Nachman
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2021
What Is the Best Maintenance Therapy for ANCA Vasculitis?Katti Woerner, Patrick H Nachman
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2023
Sparsentan and the Expanding Landscape of IgA Nephropathy TreatmentVimal K Derebail, Patrick H Nachman
Presse Medicale (Paris, France : 1983)|June 3, 2015
Recent pathogenetic advances in ANCA-associated vasculitisWilliam F Pendergraft, Patrick H Nachman
Seminars in Respiratory and Critical Care Medicine|June 16, 2011
Pathogenesis of lung vasculitisPatrick H Nachman, Ashley G Henderson
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
Persistent Hematuria in ANCA Vasculitis: Ominous or Innocuous?Shannon L Mahoney, Patrick H Nachman
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Nature Reviews. Nephrology|April 23, 2009
Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?Patrick H Nachman
Clinical Journal of the American Society of Nephrology : CJASN|May 15, 2025
Progress Toward a Better Predictor of Remission in Anti-Phospholipase A2 Receptor-Associated Membranous NephropathyPatrick H Nachman
Kidney International|September 24, 2018
Repeat kidney biopsy for lupus nephritis: an important step forwardPatrick H Nachman
Nature Reviews. Nephrology|December 14, 2020
Advances in ANCA-associated vasculitis and lupus nephritisIsabelle Ayoub, Patrick H Nachman
Bone Marrow Transplantation|August 19, 2023
Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disordersVeronika Bachanova, Patrick H Nachman
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2021
What Is the Best Maintenance Therapy for ANCA Vasculitis?Katti Woerner, Patrick H Nachman
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2023
Sparsentan and the Expanding Landscape of IgA Nephropathy TreatmentVimal K Derebail, Patrick H Nachman
Presse Medicale (Paris, France : 1983)|June 3, 2015
Recent pathogenetic advances in ANCA-associated vasculitisWilliam F Pendergraft, Patrick H Nachman
Seminars in Respiratory and Critical Care Medicine|June 16, 2011
Pathogenesis of lung vasculitisPatrick H Nachman, Ashley G Henderson
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
Persistent Hematuria in ANCA Vasculitis: Ominous or Innocuous?Shannon L Mahoney, Patrick H Nachman
Pageof 9